SUPER BUGS Act of 2024

The SUPER BUGS Act of 2024 requires the U.S. State Department, in coordination with Health and Human Services and USAID, to develop a strategy within 540 days for securing international partnerships to accelerate the development and commercialization of products addressing pandemic or epidemic threats, particularly antimicrobial-resistant pathogens. The strategy must establish equitable global collaborations with foreign governments and organizations to avoid duplication, align with U.S. pandemic preparedness plans, and prioritize funding for the most impactful health solutions. It directly affects U.S. federal agencies, international partners, and entities involved in creating medical tools for infectious diseases like antibiotic-resistant bacteria. Key mechanisms include creating standardized partnership processes, ensuring fair resource allocation based on contributors' capabilities, and integrating with existing U.S. strategies such as the National Strategy for Combating Antibiotic-Resistant Bacteria. The bill focuses on structural coordination rather than specific product approvals or funding amounts.